Identification of Drug Related Problems (DRPs) in Rheumatoid Arthritis Patients at Palembang City Hospital
Downloads
Background: Rheumatoid arthritis is a chronic systemic inflammatory arthritis disease that affects mainly synovial joints. The incident of RA can lead to the emergence of complications or comorbidities, which then allows patients to receive a variety of therapies that can trigger the incidence of DRPs during the treatment. The prevalence of RA in Indonesia itself in 2018 has reached 7.30%, with the highest percentage occurring in the elderly age group and more prevalent in women. Objective: This study aimed to determine the incidence of DRPs in RA patients in Palembang city hospitals based on the category of DRPs identified as related to drug selection and dose selection problems, as the relationship between demographic factors and the incidence of DRPs. Methods: This research is non-experimental study conducted with a retrospective cross-sectional survey. Data collection was carried out by looking at patient medical record data at X and Y Hospital in Palembang from January 2021 to March 2023. Results: The results showed that the most frequent drps in the drug selection category were drug interactions (72.03%), while in the dose selection category were insufficient dosage regimens (60.74%). The results of bivariate analysis between the incidence of DRPs and gender (p=0.809), age (p=0.879), the number of drugs used (p=0.001), and comorbidities (p=0.089). Conclusion: There is no relationship between demographic factors and comorbidities with the incidence of DRPs, and there is a relationship between the number of drugs and the incidence of DRPs.
Cipolle, R. J., Strand, L. M. & Morley, P. C. (1998). Pharmaceutical Care Practice; 73-119. New York: The McGraw Hill Companies.
Elsi, M. (2018). Gambaran faktor dominan pencetus arthritis rheumatoid. Menara Ilmu; 12; 98–106.
Hasan, D. & Mumtazah, N. (2016). Identifikasi Potensial Drug Related Problem (DRPs) Pada Pasien Rheumatoid Artritis Rawat Jalan di Rumah Sakit Umum Pusat Fatmawati Jakarta 2016. Kongres XX & Pertemuan Ilmiah Tahunan Ikatan Apoteker Indonesia 2018; 396-404.
Healthy Bones Australia. (2022). Rheumatoid Arthritis and Bone Health. https://healthybonesaustralia.org.au/wp-content/uploads/2022/10/hba-fact-sheet-rheumatoid-arthritis.pdf. Accessed: 20 November 2022
Jeong, H., Sun, Y.B., Seon, W.K., Yeong, H.E., In, Y.K., Hyungjin, K., Jaejoon, L., Eun-Mi, K., & Hoon-Suk, C. (2017). Comorbidities of rheumatoid arthritis: Results from the Korean National Health and Nutrition Examination Survey. PLOS ONE; 12; 1–15. doi: 10.1371/journal.pone.0176260.
Kemenkes RI. (2018). Laporan Nasional Riskesdas 2018. https://www.kemkes.go.id/article/view/19093000001/penyakit-jantung-penyebab-kematian-terbanyak-ke-2-di-indonesia.html. Accessed: 20 November 2022
Liu, Y.J., Hai-bing, M., Shu, L., & Zhen, C. (2022). Association between rheumatoid arthritis and thyroid dysfunction: A meta-analysis and systematic review. Front Endocrinol; 13; 6-11. doi: 10.3389/fendo.2022.1015516.
Ma, S. N., Huri, H. Z. & Yahya, F. (2019). Drug-related problems in patients with rheumatoid arthritis. Therapeutics and Clinical Risk Management; 15; 505–524. doi: 10.2147/TCRM.S194921.
Mahagna, H., Alyssa, C., Abdulla, W., Nicola, L.B., Kassem, S., Shmuel, T., Naim, M., Hen, H., Yehuda, S., Doron, C., Arnon, D.C., & Howard, A. (2018). Rheumatoid arthritis and thyroid dysfunction: A cross-sectional study and a review of the literature. Best Practice and Research: Clinical Rheumatology; 32; 683–691. doi: 10.1016/j.berh.2019.01.021.
Penn Medicine. (2022). Hypothyroidism (Underactive Thryoid). https://www.pennmedicine.org/for-patients-and-visitors/patient-information/conditions-treated-a-to-z/hypothyroidism-underactive-thyroid#:~:text=The%20most%20common%20cause%20of,system%20attacking%20the%20thyroid%20gland. Accessed: 11 Juli 2023
Sah, S. K., Ramaswamy, S. & Ramesh, M. (2022). Frequency and risk factors for the development of drug related problems among rheumatoid arthritis patients. Clinical Epidemiology and Global Health; 13; 3-5. doi: 10.1016/j.cegh.2022.100969.
Savitri, S.A., Pudjiastuti, K., Andri, R.R., & Suci, N.V. (2019). Hubungan Pemilihan Obat dan Keberhasilan Terapi Pasien Rheumatoid Arthritis. Indonesian Journal of Clinical Pharmacy; 8; 237-245. doi: 10.15416/ijcp.2019.8.4.237.
Susarti, A. & Romadhon, M. (2019). Faktor-faktor yang berhubungan dengan kejadian Rheumatoid Arthritis pada lansia. Jurnal ’Aisyiyah Medika; 4; 3. doi: 10.36729/jam.v4i3.202
Syarifuddin. (2019). Imunologi Dasar: Prinsip Dasar Sistem Kekebalan Tubuh. 6-7. Makassar: Cendekia Publisher.
Wahid, F. A. Z., Puguh, K. S. & Victoria, A. Z. (2021). Hubungan Faktor Spiritual Dan Faktor Demografi ( Usia , Jenis Kelamin , Pendidikan dan Pekerjaan ) Terhadap Kualitas Hidup Penderita Rheumatoid Arthritis. Prosiding Seminar Nasional UNIMUS; 4; 1179–1196.
Waluyo, S. & Budhi, M. (2014). Penyakit-Penyakit Autoimun. Jakarta: Elex Media Komputindo.
Copyright (c) 2024 JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
1. The copyright of this journal belongs to the Editorial Board and Journal Manager with the author's knowledge, while the moral right of the publication belong to the author.
2. The formal legal aspect of journal publication accessibility refers to the Creative Commons Attribution-Non-Commercial-Share Alike (CC BY-NC-SA), which implies that the publication can be used for non-commercial purposes in its original form.
3. Every publication (print/electronic) is open access for educational, research, and library purposes. In addition to the objectives mentioned above, the editorial board is not responsible for copyright infringement
.jpg)
